State University of New York at Buffalo
Buffalo, New York
Ekram Ahmed Chowdhury is currently an Industry sponsored postdoctoral associate at SUNY Buffalo in Dr. Shah's lab. His postdoctoral work involves the development of PBPK as well as a PK/PD model to support the clinical translation of Adeno-Associated Virus (AAV) mediated Brain Delivery of Antibodies.
Ekram completed his Ph.D. from Dr. Bickel’s lab at the Department of Pharmaceutical Sciences in Texas Tech University Health Sciences Center. The focus of his PhD project was related to the development, validation and application of a bioanalytical method of a BBB passive permeability markers. The technique was used to assess limitations in currently used non-compartmental pharmacokinetic techniques for measuring brain uptake when compared to a 3 Compartment semi-physiologic model. Additionally, he also worked on the development and characterization of an Antibody mediated targeted delivery system for oligonucleotides.
Prior to his graduate education, Ekram also worked at Novartis and Square Pharmaceuticals Ltd. in Bangladesh for 5 years where he gained valuable insights on formulation development and optimization, scale-up, process validation as well as tech transfer of products.